يعرض 1 - 10 نتائج من 12 نتيجة بحث عن '"Carrier state"', وقت الاستعلام: 0.89s تنقيح النتائج
  1. 1
  2. 2
    تقرير
  3. 3
    تقرير
  4. 4
    تقرير
  5. 5
    تقرير
  6. 6
    تقرير
  7. 7
    تقرير

    المصدر: Observational Study of Neurofilament Light Chain (NfL) Levels in Asymptomatic Carriers of the TTR Gene Variants and Patients With hATTR Amyloidosis With Polyneuropathy, Including Patients Who Undergo Treatment Change - NeuroFeeL Study

  8. 8
    تقرير

    المساهمون: Philip Polgreen, Professor, Internal Medicine

    المصدر: The Effects of the CF Carrier State on the Kidneys and Pancreas

  9. 9
    تقرير

    المساهمون: Philip Polgreen, Professor, Internal Medicine

    المصدر: Estimating the Risk for and Severity of Respiratory Infections Attributable to CFTR Heterozygosity

  10. 10
    تقرير

    المساهمون: José Antonio Martinez, MD, PhD, Senior Consultor, Assistant Profesor of Medicine (University of Barcelona)

    المصدر: Gnnella M, TrecarhEM, De Rosa FG, Del Bono V, BassettM, Lew RE, Loso AR, Corcne S, SafftC, BartolettM, Maro G, Cardello CS, TedeschS, Cauda R, VcolC, Vle P, Tumbarello M. Rk factors for carbapenem-restant Klebslla pneumone bloodstream fectn among rectal carrrs: a prospecte observatnal multentre study. Cl Mrobl fect. 2014 Dec;20(12):1357-62. do 10.1111/1469-0691.12747. Epub 2014 Aug 11.
    Am S, MhalH, Kotlovsky T, Schwaber MJ, CarmelY. Bloodstream fectns among carrrs of carbapenem-restant Klebslla pneumone: etlogy, cence and predtors. Cl Mrobl fect. 2015 Jan;21(1):30-4. do 10.1016/j.cm2014.08.001. Epub 2014 Oct 12.
    Gmen C, RossolGM, PcchA, Bertaa A, Pap G, Pastore D, Sa S, Severo A, Cudlo L, CerF, Sce R, LombardL, VcolC, RambaldA; Gruppo alno Trapnto Mollo Osseo (GMO); Gruppo alno Trapnto Mollo Osseo GMO. fectns by carbapenem-restant Klebslla pneumone SCT recnts: a natnwe retrospecte survey from aly. Bone Marrow Transplant. 2015 Feb;50(2):282-8. do 10.1038/bmt.2014.231. Epub 2014 Oct 13.
    Gnnella M, BartolettM, MorellMC, TedeschS, CrtF, Tumtto F, PasqualE, Danese CampolC, Laur ND, Faenza S, ErcolanG, Lew R, Pna AD, Vle P. Rk factors for fectn wh carbapenem-restant Klebslla pneumone after ler transplantatn: the portance of pre- and posttransplant colonatn. Am J Transplant. 2015 Jun;15(6):1708-15. do 10.1111/ajt.13136. Epub 2015 Mar 4.
    Septus EJ, Schweer ML. Decolonatn Preventn of Health Care-Assocted fectns. Cl Mrobl Rev. 2016 Apr;29(2):201-22. do 10.1128/CMR.00049-15.
    Huttner B, Hauste T, Uckay RenzG, Stewardson A, Schaerrer D, Agostho A, Andremont A, Schrenzel J, Ptet D, Harbarth S. Decolonatn of testal carrge of extended-spectrum beta-lactamase-producg Enterobacterceae wh oral colt and neomyc: a randomed, double-bld, placebo-controlled trl. J Antrob Chemother. 2013 Oct;68(10):2375-82. do 10.1093/jac/dkt174. Epub 2013 May 29.
    Rg S, Kupper MF, de Wh K, Serr A, Bohnert JA, Kern WV. testal decolonatn of Enterobacterceae producg extended-spectrum beta-lactamases (ESBL): a retrospecte observatnal study patnts at rk for fectn and a brf revw of the lerature. BMC fect D. 2015 Oct 28;15:475. do 10.1186/s12879-015-1225-0.
    Machuca Gutrrez-Gutrrez B, Perez Cortes S, Grac-Ahufger Serrano J, Madral MD, Barcala J, Rodruez-Lopez F, Rodruez-Bano J, Torre-Cneros J. Oral decontamatn wh amoglycoses assocted wh lower rk of mortaly and fectns hh-rk patnts coloned wh colt-restant, KPC-producg Klebslla pneumone. J Antrob Chemother. 2016 Nov;71(11):3242-3249. do 10.1093/jac/dkw272. Epub 2016 Jul 26.
    Bar-Yoseph H, Husse K, Braun E, Paul M. Natural htory and decolonatn strategs for ESBL/carbapenem-restant Enterobacterceae carrge: systemat revw and meta-analys. J Antrob Chemother. 2016 Oct;71(10):2729-39. do 10.1093/jac/dkw221. Epub 2016 Jun 17.
    Lubbert C, Faucheux S, Becker-Rux D, LaudS, Durrbeck A, Busch T, Gastmer P, Eckmanns T, Rodloff AC, Kaers UX. Rap emergence of secondary restance to gentam and colt followg selecte deste decontamatn patnts wh KPC-2-producg Klebslla pneumone: a sgle-centre expernce. t J Antrob Agents. 2013 Dec;42(6):565-70. do 10.1016/j.antag.2013.08.008. Epub 2013 Sep 19.
    TascC, Sbrana F, FlammS, TaglferrE, Arena F, LeondA, Cllo AmadorF, DPaolo A, RolA, Lew R, RossolGM, MenhettF; GENGUT Study Group. Oral gentam gut decontamatn for preventn of KPC-producg Klebslla pneumone fectns: relevance of concomant system antt therapy. Antrob Agents Chemother. 2014;58(4):1972-6. do 10.1128/AAC.02283-13. Epub 2014 Jan 13.
    Oren Sprecher H, Fkelste R, Hadad S, Neuberger A, Husse K, Raz-Pasteur A, LavN, Saad E, Hen Horowz N, Av BenyamN, Feman R, Ofran Y, Haddad N, Rowe JM, Zuckerman T. Eradatn of carbapenem-restant Enterobacterceae gastrotestal colonatn wh nonabsorbable oral antt treatment: A prospecte controlled trl. Am J fect Control. 2013 Dec;41(12):1167-72. do 10.1016/j.aj.2013.04.018.
    de Jonge E, Schultz MJ, Spanjaard L, Bossuyt PM, Vroom MB, Dankert J, Kesecglu J. Effects of selecte decontamatn of deste tract on mortaly and acqun of restant bacter tense care: a randomed controlled trl. Lancet. 2003 Sep 27;362(9389):1011-6. do 10.1016/S0140-6736(03)14409-1.
    de Smet AM, Kluytmans JA, Cooper BS, MascEM, Benus RF, van der Werf TS, van der Hoeven JG, Pkkers P, Bogaers-Hofman D, van der Meer NJ, Bernards AT, Kuper EJ, Joore JC, Leverste-van Hall MA, Bdels AJ, Jansz AR, Wesselk RM, de Jongh BM, Dennesen PJ, van Asselt GJ, te Velde LF, Frenay , Kaasjager K, Bosch FH, van erson M, Thsen SF, Kluge GH, Pauw W, de Vrs JW, Kaan JA, Arends JP, Aarts LP, Sturm PD, Harck H Voss A, Utendaal EV, Blok HE, Thme Groen ES, Pouw ME, Kalkman CJ, Bonten MJ. Decontamatn of the deste tract and oropharynx U patnts. N Engl J Med. 2009 Jan 1;360(1):20-31. do 10.1056/NEJMoa0800394.
    Oostdk EA, Sms L, de Smet AM, Leverste-van Hall MA, Kesecglu J, Bonten MJ. Colt restance gram-negate bacter durg prophylact topal colt use tense care uns. tense Care Med. 2013 Apr;39(4):653-60. do 10.1007/s00134-012-2761-3. Epub 2012 Dec 1.
    Oostdk EAN, Kesecglu J, Schultz MJ, Vser CE, de Jonge E, van Essen EHR, Bernards AT, Purmer Brombe R, Bergmans D, van Tl F, Bosch FH, MascE, van Grthuysen A, Bdels A, Jansz A, van Stevenck FAL, van der Zwet WC, Fen JW, Thsen S, de Jong R, Oudbr J, Raben A, van der Vorm E, Koeman M, Rothbarth P, Rkeboer A, Gruteke P, Hart-Sweet H, Peerbooms P, Wsser LJ, van Elsacker-Nle AW, Demmendaal K, Brandenburg A, de Smet AMGA, Bonten MJM. Effects of decontamatn of the oropharynx and testal tract on antt restance Us: a randomed clal trl. JAMA. 2014 Oct 8;312(14):1429-1437. do 10.1001/jama.2014.7247.
    Wtekamp BH, Plantga NL, Cooper BS, Lopez-Contreras J, Coll P, Mancebo J, We MP, Morgan MPG, Depuydt P, Boelens J, Dugernr T, Verbelen V, Jorens PG, Verbrugghe W, Malhotra-Kumar S, Damas P, Meex C, Leleu K, van den Abeele AM, Gomes Penta de Matos AF, Fernandez Mendez S, Vergara Gomez A, Tom V, Srer F, Vlarreal Tello E, Ru Ramos J, Aragao Santos C, Sperng RHM, Coppadoro P, NardG, Brun-Buson C, Bonten MJM. Decontamatn Strategs and Bloodstream fectns Wh Antt-Restant Mroorganms Ventated Patnts: A Randomed Clal Trl. JAMA. 2018 Nov 27;320(20):2087-2098. do 10.1001/jama.2018.13765.
    Shayto RH, Abou Mrad R, Sharara A Use of rax gastrotestal and ler deases. World J Gastroenterol. 2016 Aug 7;22(29):6638-51. do 10.3748/wjg.v22.9.6638.
    Mazde PJ, Perea P, Goldste EJ. A Decade of Expernce Prary Preventn of Clostrm dfe fectn at a Communy Hospal Usg the Probt Combatn Lactobaclus acophus CL1285, Lactobaclus caseLBC80R, and Lactobaclus rhamnosus CLR2 (B-K+). Cl fect D. 2015 May 15;60 Suppl 2:S144-7. do 10.1093/c/c178.
    Crum-Cnflone NF, Sullan E, Ballon-Landa G. Fecal mrobta transplantatn and successful resolutn of multrug-restant-organm colonatn. J Cl Mrobl. 2015 Jun;53(6):1986-9. do 10.1128/JCM.00820-15. Epub 2015 Apr 15.
    Manges AR, Steer TS, Wrht AJ. Fecal mrobta transplantatn for the testal decolonatn of extensely antrobl-restant opportunt pathogens: a revw. fect D (Lond). 2016 Aug;48(8):587-92. do 10.1080/23744235.2016.1177199. Epub 2016 May 19.
    Davo B, Salomon J, Lawrence C, Duran C, Batta R, de Truch P, Dh A. pact of Fecal Mrobta Transplantatn for Decolonatn of Multrug-Restant Organms May Vary Accordg to Donor Mrobta. Cl fect D. 2018 Apr 3;66(8):1316-1317. do 10.1093/c/c963. No abstract avaable.
    Saha S, Tar R, Tosh PK, PardDS, Khanna S. Faecal mrobta transplantatn for eradatg carrge of multrug-restant organms: a systemat revw. Cl Mrobl fect. 2019 Aug;25(8):958-963. do 10.1016/j.cm2019.04.006. Epub 2019 Apr 12.
    BskJ, GrzeswskP, Sorensen N, Madry K, MuszynskJ, Robak K, Wroblewska M, DzctkowskT, Dulny G, Dwewz-Trojaczek J, Wtor-Jedrzejczak W, Basak GW. Fecal Mrobta Transplantatn Patnts Wh Blood Dorders hs Gut Colonatn Wh Antt-Restant Bacter: Results of a Prospecte, Sgle-Center Study. Cl fect D. 2017 Aug 1;65(3):364-370. do 10.1093/c/c252.
    Huttner BD, de Lastours V, Wassenberg M, Maharshak N, Maur A, Galpere T, ZanhellV, Kapel N, Bellanger A, Olearo F, Duval X, Armand-Lefevre L, CarmelY, Bonten M, Fant B, Harbarth S; R-Gnos WP3 study group. A 5-day course of oral antts followed by faecal transplantatn to eradate carrge of multrug-restant Enterobacterceae: a randomed clal trl. Cl Mrobl fect. 2019 Jul;25(7):830-838. do 10.1016/j.cm2018.12.009. Epub 2019 Jan 4.
    Tar R, PardDS, Bartlett MG, Khanna S. Low Cure Rates Controlled Trls of Fecal Mrobta Transplantatn for Recurrent Clostrm dfe fectn: A Systemat Revw and Meta-analys. Cl fect D. 2019 Apr 8;68(8):1351-1358. do 10.1093/c/c721.
    Open-label, Randomized Study to Assess the Efficacy of a Probiotic or Fecal Microbiota Transplantation (FMT) on the Eradication of Rectal Multidrug-resistant Gram-negative Bacilli (MDR-GNB) Carriage (PROFTMDECOL)